Gladius Pharmaceuticals
Wilmington, US · Founded 2015
Biotech
Founders & leadership
MA
Michael AtkinExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$3MraisedNov 2018 · 5 investors · Biotechnology
Rule 506(b)$727.8KraisedJun 2015 · 2 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.